company background image
3737 logo

Zhongzhi Pharmaceutical Holdings SEHK:3737 주식 보고서

최종 가격

HK$0.98

시가총액

HK$846.3m

7D

3.2%

1Y

-26.3%

업데이트

28 Sep, 2024

데이터

회사 재무

Zhongzhi Pharmaceutical Holdings Limited

SEHK:3737 주식 보고서

시가총액: HK$846.3m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

3737 주식 개요

투자 지주 회사인 중즈 제약 홀딩스는 중화인민공화국에서 의약품의 연구, 개발, 제조 및 판매에 종사하는 회사입니다.

3737 기본 분석
눈송이 점수
가치 평가2/6
미래 성장0/6
과거 실적2/6
재무 상태5/6
배당금0/6

Zhongzhi Pharmaceutical Holdings Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Zhongzhi Pharmaceutical Holdings
과거 주가
현재 주가HK$0.98
52주 최고치HK$1.56
52주 최저치HK$0.82
베타0.48
11개월 변경-2.00%
3개월 변경 사항-21.60%
1년 변경 사항-26.32%
33년 변화-11.71%
5년 변화-32.41%
IPO 이후 변화-59.00%

최근 뉴스 및 업데이트

Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Aug 22
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Recent updates

Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Aug 22
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding

Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Jun 19
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

May 10
Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

Feb 01
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

May 24
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Aug 26
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

Apr 28
Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

May 06
Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

Mar 29
Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Mar 05
The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 15
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Jan 14
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

Dec 27
Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Dec 14
If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Nov 30
Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 17
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

주주 수익률

3737HK PharmaceuticalsHK 마켓
7D3.2%8.8%10.9%
1Y-26.3%18.4%13.4%

수익률 대 산업: 3737 지난 1년 동안 -6.1 %를 반환한 Hong Kong Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: 3737 지난 1년 동안 -5.9 %를 반환한 Hong Kong 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is 3737's price volatile compared to industry and market?
3737 volatility
3737 Average Weekly Movement7.2%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement6.8%
10% most volatile stocks in HK Market13.8%
10% least volatile stocks in HK Market3.5%

안정적인 주가: 3737 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: 3737 의 주간 변동성( 7% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19932,736Ying Feng Laiwww.zeus.cn

투자 지주 회사인 중즈 제약 홀딩스는 중화 인민 공화국에서 의약품의 연구, 개발, 제조 및 판매에 종사하고 있습니다. 이 회사는 의약품 제조 및 체인 약국 운영 부문을 통해 운영됩니다. 제우스, 리우미안, 카오징화 브랜드로 중국 특허 의약품과 달인 약을 제공합니다.

Zhongzhi Pharmaceutical Holdings Limited 기본 사항 요약

Zhongzhi Pharmaceutical Holdings 의 수익과 매출은 시가총액과 어떻게 비교하나요?
3737 기본 통계
시가총액HK$846.33m
수익(TTM)HK$123.39m
수익(TTM)HK$2.27b

6.9x

P/E 비율

0.4x

P/S 비율

3737 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
3737 손익 계산서(TTM)
수익CN¥2.04b
수익 비용CN¥877.22m
총 이익CN¥1.17b
기타 비용CN¥1.06b
수익CN¥111.32m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)0.13
총 마진57.08%
순이익 마진5.45%
부채/자본 비율6.7%

3737 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기